The Brazilian Health Regulatory Agency received a temporary authorization request for the Chinese immunizer Sinopharm. It has not undergone clinical trials in Brazil but has been tested in countries like the United Arab Emirates, Egypt, Argentina, and Peru.
LATEST NEWS
- Syria’s bank opens tender for IT services
- Brazilians and Arabs take part in kung fu session
- Brazil’s Resende courts Arab market
- Kuwait, Syria open markets to Brazilian products
- Brazil explores agricultural partnerships in Egypt
- Kuwait expands digital payments to 84%
- Algeria opens market to Brazil’s distillers grains
- Qatar opens applications for edtech accelerator
